79 related articles for article (PubMed ID: 2788713)
21. Cell-mediated cytotoxicity in vitro of human lymphocytes against a cervical cancer cell line.
Mashiba H; Matsunaga K; Ueno M; Jimi S
Gan; 1977 Feb; 68(1):53-8. PubMed ID: 558932
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic reactivity of human natural killer (NK) cells during normal pregnancy: a longitudinal study.
Gregory CD; Shah LP; Lee H; Scott IV; Golding PR
J Clin Lab Immunol; 1985 Dec; 18(4):175-81. PubMed ID: 3879503
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
Damle NK; Doyle LV; Bradley EC
J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
[TBL] [Abstract][Full Text] [Related]
24. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Izquierdo M; López-Botet M
J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
[TBL] [Abstract][Full Text] [Related]
25. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
[TBL] [Abstract][Full Text] [Related]
26. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
LeFever AV; Funahashi A
Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
[TBL] [Abstract][Full Text] [Related]
27. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
28. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
[TBL] [Abstract][Full Text] [Related]
29. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G
Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886
[TBL] [Abstract][Full Text] [Related]
30. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
31. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
32. [Immunophenotyping of lymphocyte subpopulations using monoclonal antibodies in an analytical flow cytometer: evaluation of the method and reference values].
Neumeier D; Pauls R; Wifling I; Fateh-Moghadam A; Knedel M
J Clin Chem Clin Biochem; 1985 Nov; 23(11):765-75. PubMed ID: 4086981
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte subpopulations in patients with cervical intraepithelial neoplasia.
Andersen ES; Christiansen OB; Jersild C; Larsen G
Gynecol Oncol; 1990 Jul; 38(1):125-7. PubMed ID: 2354817
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix.
Vaquer S; Jordá J; López de la Osa E; Alvarez de los Heros J; López-García N; Alvarez de Mon M
Gynecol Oncol; 1990 Jan; 36(1):90-2. PubMed ID: 2295458
[TBL] [Abstract][Full Text] [Related]
35. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
Uchida A; Yanagawa E
J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
[TBL] [Abstract][Full Text] [Related]
36. Defective natural killer activity in gastric cancer patients: possible involvement of suppressor factor receptor.
Yamaguchi Y; Takashima I; Funakoshi M; Kawami H; Toge T
In Vivo; 1994; 8(3):279-83. PubMed ID: 7803704
[TBL] [Abstract][Full Text] [Related]
37. [Two color analysis of peripheral lymphocyte subsets in patients with cancers during and after radiotherapy].
Nakatsugawa S; Kimoto T; Takahashi N; Kimura H; Takabatake M; Yamada H; Maeda M; Yamamoto K; Suto Y; Kimura K
Gan No Rinsho; 1988 Oct; 34(13):1789-98. PubMed ID: 3264350
[TBL] [Abstract][Full Text] [Related]
38. Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
Hogan PG; Hapel AJ; Doe WF
J Immunol; 1985 Sep; 135(3):1731-8. PubMed ID: 3926882
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic activity of NK cells against SW-756 squamous cervical carcinoma cell line: role of interferons alpha and gamma and CD54 adhesion molecule in oncolysis.
Cristoforoni PM; Lotzová E; Cook KR; Chuang LT; Morris M; Grossi CE; Wharton JT
Gynecol Oncol; 1994 Mar; 52(3):365-72. PubMed ID: 7512522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
